Kenichi Tanaka to Purinergic P2Y Receptor Antagonists
This is a "connection" page, showing publications Kenichi Tanaka has written about Purinergic P2Y Receptor Antagonists.
Connection Strength
0.874
-
Influences of hemodilution and anticoagulation on antiplatelet P2Y12 therapy: in vitro whole blood perfusion model. J Cardiothorac Vasc Anesth. 2013 Dec; 27(6):e69-71.
Score: 0.441
-
Hemostasis Management of Patients Undergoing Emergency Cardiac Surgery After Ticagrelor Loading. J Cardiothorac Vasc Anesth. 2020 Jan; 34(1):168-174.
Score: 0.164
-
Interaction Between Ticagrelor and CYP3A4 Inhibitor: Importance of P2Y12 Function Testing to Assess Platelet Recovery Before Surgery. J Cardiothorac Vasc Anesth. 2019 11; 33(11):3221-3222.
Score: 0.162
-
In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel. Thromb Res. 2013 Jul; 132(1):106-11.
Score: 0.107